Evotec stock heads into the open after a 3.0% Xetra loss
Published on 09/11/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec stock closed at EUR 3.04 on Xetra on September 10, 2026, a loss of 3.0 percent compared with the previous Xetra close of EUR 3.14 per exchange data. The share traded between a day low of EUR 2.99 and a day high of EUR 3.16, leaving the close just above the new 52-week low marked in the same session. Per Xetra statistics reported by Finanzen.net, volume for the session reached 794,436 shares, indicating active trading around this depressed price level.
September 10, 2026 in numbers
Evotec SE (ISIN DE0005664809, Xetra: EVT) started the September 10, 2026 Xetra session at EUR 3.16, before slipping intraday to as low as EUR 2.99 and finally settling at EUR 3.04 at 17:35 CET, 3.0 percent below the prior closing price of EUR 3.14 according to quote tables at Finanzen.net. The same overview shows that the fresh 52-week low for Evotec shares now stands at EUR 2.99, set during that session, while the 52-week high of EUR 7.30 dates back to October 27, 2025, underlining the extent of the longer term drawdown in the stock. Finanzen.ch noted that intraday quotes earlier in the day hovered around EUR 3.13 to EUR 3.14, with only small percentage changes, before the late-session selling pressure pushed the price down toward the new low.Finanzen.net Coverage at Finanzen.ch also emphasized how Evotec shares are currently fluctuating narrowly around the EUR 3.10 mark as investors continue to digest the companys recent quarterly figures and the weak share price performance in 2026.Finanzen.ch
Regulatory filing and today’s focus
Alongside the price move, Evotec published a regulatory notification on September 10, 2026 under Article 40 of the German Securities Trading Act, reporting voting rights information, which kept the company in the news flow ahead of todays session.Deutsche Boerse In a separate commentary on September 10, 2026, Trading-Treff highlighted that the Evotec share recently traded around EUR 3.06 and only about 1.9 percent above a 52-week low near EUR 3.00, with a decline of roughly 61 percent from a year high of EUR 7.75 reached in November of the previous year, underscoring the ongoing pressure on the stock.Trading-Treff As todays Xetra session approaches, investors may keep an eye on further reactions to these voting rights disclosures and the broader biotech sector sentiment, while the next set of detailed financial results has already been reported for the quarter ended June 30, 2026 and is therefore not due today.
